Saar Gill, MD, PhD

Saar Gill, MD, PhD, is the Scientific Co-Director, Cell Therapy and Transplant Program and Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania. Dr. Gill obtained his medical degree and PhD in immunology from the University of Melbourne, and trained in hematology at St Vincent’s Hospital, the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. In 2008 he moved to the United States, first to pursue a post-doctoral fellowship in cellular therapy at Stanford University, and then in 2011 to the University of Pennsylvania where he is now an associate professor of medicine. Dr. Gill’s clinical practice is in leukaemia and bone marrow transplantation. He has led clinical trials of chimeric antigen receptor (CAR) T cells for chronic and acute leukemias. Dr. Gill’s research laboratory focuses on the interface between adoptive cellular therapy and genetic engineering, with a strong translational focus. Dr. Gill has authored over 100 peer-reviewed papers and is listed as an inventor on over 60 patents. He has spun out two biotechnology companies that currently employ over 100 people in Philadelphia. Dr. Gill’s past trainees hold independent academic appointments at the University of Melbourne, the Israel Institute of Technology, Mayo Clinic, Washington University, and at the University of Pennsylvania School of Medicine.